Skip to Content
Merck
CN
All Photos(1)

Key Documents

AB324P

Sigma-Aldrich

Donkey Anti-Sheep/Goat IgG Antibody, HRP conjugate

Chemicon®, from donkey

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46

biological source

donkey

conjugate

peroxidase conjugate

antibody form

affinity purified immunoglobulin

antibody product type

secondary antibodies

clone

polyclonal

species reactivity

sheep, goat

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
western blot: suitable

shipped in

wet ice

General description

Affinity purified donkey anti sheep / goat immunoglobulin, HRP conjugated. Cross reactivity to human, rabbit, and mouse proteins is less than 2% by ELISA.

Application

Donkey Anti-Sheep/Goat IgG Antibody, HRP conjugate detects level of Donkey Sheep/Goat IgG & has been published & validated for use in ELISA & WB.
ELISA: 1:1,000-1:20,000

Immunoblotting: 1:100-1:2,000

Optimal working dilutions must be determined by the end user.
Research Category
Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies

Quality

The antibody is isolated from antisera by affinity purification. Undesired immune reactivity has been removed by solid phase adsorption.

Linkage

Replaces: AP305P

Physical form

ImmunoAffinity Purified
The conjugate is supplied in phosphate buffered saline, pH 7.2, with 0.5% (w/v) bovine serum albumin and 10% (w/v) glycerol, 0.04% Thymol plus 0.4% anti microbial preservative

Storage and Stability

Maintain at 2-8°C in undiluted aliquots for up to 6 months.

Use of sodium azide as a preservative will substantially inhibit the enzyme activity of HRP.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Aquatic Chronic 3 - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Rachael Bartlett et al.
PeerJ, 5, e3064-e3064 (2017-03-08)
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease characterised by the accumulation of aggregated proteins, microglia activation and motor neuron loss. The mechanisms underlying neurodegeneration and disease progression in ALS are unknown, but the ATP-gated P2X7 receptor channel
Miriam Burmeister et al.
Science advances, 9(29), eadg0686-eadg0686 (2023-07-19)
The gelatinases, matrix metalloproteinase 2 (MMP-2) and MMP-9, are key for leukocyte penetration of the brain parenchymal border in neuroinflammation and the functional integrity of this barrier; however, it is unclear which MMP substrates are involved. Using a tailored, sensitive
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.
Epis, MR; Giles, KM; Kalinowski, FC; Barker, A; Cohen, RJ; Leedman, PJ
The Journal of Biological Chemistry null
Rachael Bartlett et al.
Purinergic signalling (2022-04-29)
Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to naïve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1
Manabu Koike et al.
FEBS open bio, 9(6), 1052-1062 (2019-05-23)
Resistance to radiotherapy and chemotherapy is a common problem in the treatment of cancer in humans and companion animals, including cats. There is thus an urgent need to develop new treatments. Molecularly targeted therapies hold the promise of high specificity

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service